| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8dc1442e8263a086103a8b2a6b9753f9 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-285
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-863 |
| filingDate |
2015-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ae5f3f1b7851b96df7a44631f8315225
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f273e3253ad48acbb918f2529ca395fb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2a62d068524c9996244dd604c7be3ee1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_731633e53f29135df7ee085c4e842eb8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ec7e8e454124bf4555c1d7e842e2c717 |
| publicationDate |
2015-08-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
AU-2015203893-A1 |
| titleOfInvention |
Optimized early-late promoter combined with repeated vaccination favors cytotoxic t cell response against antigens in replication deficient recombinant virus vaccines |
| abstract |
Abstract The present invention relates to a replication deficient recombinant virus encoding at least one antigen and/or antigenic epitope, wherein expression of said antigen and/or 5 antigenic epitope is regulated by a transcriptional control element comprising at least two elements driving early expression of said antigen and/or antigenic epitope and the use of said replication deficient recombinant virus as medicament or vaccine. |
| priorityDate |
2009-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |